Dadu, A. Early adopters of 6-month levofloxacin as rifampicin-resistant tuberculosis preventive treatment regimen in the WHO European Region, 2023. European Centre for Disease Prevention and Control.
Chicago Style (17th ed.) CitationDadu, Andrei. Early Adopters of 6-month Levofloxacin as Rifampicin-resistant Tuberculosis Preventive Treatment Regimen in the WHO European Region, 2023. European Centre for Disease Prevention and Control.
MLA (9th ed.) CitationDadu, Andrei. Early Adopters of 6-month Levofloxacin as Rifampicin-resistant Tuberculosis Preventive Treatment Regimen in the WHO European Region, 2023. European Centre for Disease Prevention and Control.
Warning: These citations may not always be 100% accurate.